Evidence map›Paper›PMID 42368927›Full record

ArticleFrontiers in public health2026

Factors influencing men to discontinue antiretroviral at Seventh Day Adventist clinic, Maseru, Lesotho.

Thabelang Rabaholo, Moganavelli Reddy

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thabelang RabaholoCollege of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Moganavelli ReddyCollege of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Discontinuation of ARV is a worldwide problem, with a discontinuation rate of 20% globally and 40-50% in Sub-Saharan Africa. In Lesotho, it ranges from 20 to 30% in men. To effectively tackle the HIV/AIDS epidemic in Lesotho, it is necessary to address the several complex problems that hinder adherence to ARVs among men. Methods: This study used a qualitative descriptive case study approach to collect data from men aged 18 years and above receiving health services at the Seventh-day Adventist clinic, using a homogeneous purposive sampling method. In-depth interviews were used to collect audio-recorded data after obtaining informed consent and 10 men who were on ART were interviewed. Results: Of the 10 clients, all had discontinued their ARVS in the past year (2023). Overall, participants identified four factors that influence most men to default on their ARVs: individual, socio-economic, culturally related, and health systems factors. Conclusion: Participant's difficulties, such as socio-economic obstacles (e.g., transportation costs and unstable employment), cultural influences based on religious and Christian norms that discourage clinic attendance, and deficiencies in the health system (e.g., lengthy wait times and rigid services) were identified by participants as interrelated factors driving men's discontinuation of ART treatment. These results necessitate that health systems take immediate, comprehensive actions, such as prioritising male-specific ART delivery modalities.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsMedication AdherenceAdultAmbulatory Care FacilitiesHumansInterviews as TopicLesothoMaleMiddle AgedQualitative ResearchSocioeconomic FactorsYoung AdultAnti-HIV AgentsAnti-Retroviral AgentsadherenceartARV’SdiscontinueHIVmen

Identifiers

PMID42368927
PMCPMC13294286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.